Form 4: Sanara MedTech CEO Zachary Fleming Reports Stock Transactions
SEC Form 4 Filing
Sanara MedTech's CEO, Zachary Fleming, reports the withholding of shares to cover tax obligations related to vesting restricted stock.
Summary
- On March 1, 2024, Zachary B. Fleming, CEO of Sanara MedTech Inc., had shares withheld by the company to cover tax obligations related to vesting restricted stock.
- 926 shares were withheld at a price of $38.96 per share related to restricted stock granted on March 8, 2022.
- 790 shares were withheld at a price of $38.96 per share related to restricted stock granted on March 2, 2023.
- No shares were issued or sold in these transactions.
- Following these transactions, Fleming directly owns 36,161 shares of Sanara MedTech Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/08/2022 | Date of restricted stock grant related to the withholding of 926 shares. |
| 03/02/2023 | Date of restricted stock grant related to the withholding of 790 shares. |
| 03/01/2024 | Date of the stock withholding transactions. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.